Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-15-2528PMID 27197152PMCID PMC4891237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer

  2014cited by this paper
• Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

  2014cited by this paper
• Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

  2014cited by this paper
• IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.

  2014cited by this paper
• Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

  2013influential reference
• Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

  2013cited by this paper
• CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis.

  2013cited by this paper
• Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells

  2012influential reference
• S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

  2012cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Human TH17 Cells Are Long-Lived Effector Memory Cells

  2011cited by this paper
• Interaction Between Notch and Hif-α in Development and Survival of Drosophila Blood Cells

  2011cited by this paper
• CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis

  2011cited by this paper
• The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

  2011influential reference
• Targeting and utilizing primary tumors as live vaccines: changing strategies

  2011cited by this paper
• Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

  2011cited by this paper
• Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.

  2010cited by this paper
• The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.

  2010cited by this paper
• Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009influential reference
• BRCA1 regulates human mammary stem/progenitor cell fate

  2008cited by this paper
• Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.

  2008cited by this paper
• Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

  2008cited by this paper
• Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

  2007influential reference
• IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.

  2007influential reference
• Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.

  2007influential reference
• Adaptive immunity maintains occult cancer in an equilibrium state

  2007cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

  2006cited by this paper
• Cancer stem cells: an old idea--a paradigm shift.

  2006cited by this paper
• Migrating cancer stem cells — an integrated concept of malignant tumour progression

  2005cited by this paper
• Immunosuppressive networks in the tumour environment and their therapeutic relevance

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

  2003cited by this paper
• Cancer immunoediting: from immunosurveillance to tumor escape

  2002cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation1

  2000cited by this paper

• Notch signaling in the tumor microenvironment: recent advances and targeted therapeutics

  2026cites this paper
• Systematic Investigation of Tumor Immune Microenvironment Modulation by Cynomorium songaricum Against Breast Cancer Through Integrated Chemomics, Network Pharmacology and Molecular Docking.

  2026cites this paper
• The role of notch signaling in regulating myeloid-derived suppressor cells: Implications in Cancer and autoimmune diseases.

  2025cites this paper
• IL1RA+ Myeloid-derived Suppressor Cells Activate Epithelial-mesenchymal Transition to Facilitate Lymphatic and Hepatic Metastasis in Pancreatic Ductal Carcinoma

  2025cites this paper
• Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy

  2025cites this paper
• Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation.

  2025cites this paper
• Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy

  2025cites this paper
• Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

  2025cites this paper
• Chronic stress drives ovarian cancer progression via myeloid-derived suppressor cells infiltration and Notch signaling pathway activation

  2025cites this paper
• Microbial-induced trained immunity for cancer immunotherapy.

  2025cites this paper
• New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy

  2025cites this paper
• MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy

  2025cites this paper
• The Regulatory Role of CTCF in IL6 Gene Transcription Assessed in Breast Cancer Cell Lines

  2025cites this paper
• MDSCs in breast cancer: metastasis, lipid metabolism, and therapeutics.

  2025cites this paper
• Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy

  2025cites this paper
• Enhancing antitumour immunity with photodynamic therapy

  2025cites this paper
• Fibrinogen: a new player and target on the formation of pre-metastatic niche in tumor metastasis.

  2025cites this paper
• Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments

  2025cites this paper
• Role of the TLR signaling pathway in the pathogenesis of glioblastoma multiforme with an emphasis on immunotherapy

  2025cites this paper
• Cancer Stem Cell and Tumor Immune Microenvironment (TIME): Dangerous Crosstalk.

  2025cites this paper
• Notch signalling in T cells: bridging tumour immunity and intratumoral cellular crosstalk

  2025cites this paper
• Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy

  2025cites this paper
• Cancer stem cells and niches: challenges in immunotherapy resistance

  2025cites this paper
• Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy

  2025cites this paper
• Glioma–Immune Cell Crosstalk in Tumor Progression

  2024cites this paper
• An insight into the role of innate immune cells in breast tumor microenvironment

  2024cites this paper
• Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics

  2024cites this paper
• Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK–induced cancer cell plasticity

  2024cites this paper
• Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy

  2024cites this paper
• Myeloid-derived suppressor cells in cancer and cancer therapy

  2024cites this paper
• Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells

  2024cites this paper
• Research progress on the multi-omics and survival status of circulating tumor cells

  2024cites this paper
• Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

  2024cites this paper
• Regulation and Pharmacology of the Cyclic GMP and Nitric Oxide Pathway in Embryonic and Adult Stem Cells

  2024cites this paper
• Reciprocal relationship between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and therapeutic strategies.

  2024cites this paper
• The role and research progress of MDSC in immune aging-related diseases

  2024cites this paper
• Protein Signature Differentiating Neutrophils and Myeloid-Derived Suppressor Cells Determined Using a Human Isogenic Cell Line Model and Protein Profiling

  2024cites this paper
• Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies

  2024cites this paper
• AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells

  2024cites this paper
• Advancements in a novel model of autophagy and immune network regulation in radioresistance of cancer stem cells.

  2024cites this paper
• Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression

  2024cites this paper
• Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.

  2024cites this paper
• Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression

  2024cites this paper
• Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer

  2024cites this paper
• Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

  2024cites this paper
• Nanomaterials for bone metastasis.

  2024cites this paper
• Mediator complex subunit 1 promotes oral squamous cell carcinoma progression by activating MMP9 transcription and suppressing CD8+ T cell antitumor immunity

  2024cites this paper
• Despicable role of epithelial–mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens

  2024cites this paper
• Co-evolution of glioma and immune microenvironment

  2024cites this paper
• Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies

  2024cites this paper
• The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma

  2023cites this paper
• Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward

  2023cites this paper
• The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.

  2023cites this paper
• Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting.

  2023cites this paper
• PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway

  2023cites this paper
• Improving cancer immunotherapy by preventing cancer stem cell and immune cell linking in the tumor microenvironment.

  2023cites this paper
• Cancer stem cell–immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet

  2023influential citation
• Cancer stem cells and their niche in cancer progression and therapy

  2023cites this paper
• Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer

  2023cites this paper
• Exploiting innate immunity for cancer immunotherapy

  2023cites this paper
• Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing.

  2023cites this paper
• Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer.

  2023cites this paper
• Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor

  2023cites this paper
• MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target

  2023influential citation
• IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation

  2023cites this paper
• The peritumor microenvironment: physics and immunity.

  2023cites this paper
• Role of the tumor microenvironment in the lymphatic metastasis of cervical cancer (Review)

  2023cites this paper
• Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer

  2023cites this paper
• The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy

  2023cites this paper
• Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

  2023cites this paper
• Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies

  2023cites this paper
• Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

  2023cites this paper
• Myeloid-derived suppressor cells in head and neck squamous cell carcinoma.

  2023cites this paper
• Targeting Breast Cancer Stem Cells

  2023cites this paper
• Combining Cryo-Thermal Therapy with Anti-IL-6 Treatment Promoted the Maturation of MDSCs to Induce Long-Term Survival in a Mouse Model of Breast Cancer

  2023cites this paper
• Cancer stem cell‐immune cell collusion in immunotherapy

  2023cites this paper
• Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment

  2023cites this paper
• Engaging stemness improves cancer immunotherapy.

  2022cites this paper
• The STAT family: key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.

  2022cites this paper
• Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics

  2022cites this paper
• Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer

  2022cites this paper
• Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation

  2022cites this paper
• Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer

  2022cites this paper
• The role of Hedgehog and Notch signaling pathway in cancer

  2022cites this paper
• Tumor-educated Gr1+CD11b+ cells instigate breast cancer metastasis by twisting cancer cells plasticity via OSM/IL6–JAK signaling

  2022cites this paper
• Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation

  2022cites this paper
• The metabolic addiction of cancer stem cells

  2022cites this paper
• Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies

  2022cites this paper
• Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells

  2022cites this paper
• Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.

  2022cites this paper
• Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?

  2022cites this paper
• MDSCs might be "Achilles heel" for eradicating CSCs.

  2022cites this paper
• Roles of Notch Signaling in the Tumor Microenvironment

  2022cites this paper
• Notch-Signaling Deregulation Induces Myeloid-Derived Suppressor Cells in T-Cell Acute Lymphoblastic Leukemia

  2022cites this paper
• Notch signaling pathway: architecture, disease, and therapeutics

  2022cites this paper
• Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis

  2022cites this paper
• Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers

  2022cites this paper
• Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression

  2022cites this paper
• The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.

  2022cites this paper
• Molecular biological mechanism of action in cancer therapies: Juglone and its derivatives, the future of development.

  2022cites this paper